FN2 Earnings Intelligence
Philip Morris International Inc. earnings overview
Latest Philip Morris International Inc. (PM) earnings intelligence, including the newest scorecard, market reaction, and transcript analysis.
Philip Morris International Inc.
The quarter supports a constructive but qualified view of Philip Morris's growth trajectory: resilient demand and continued smoke-free share gains are positive, while U.S. investment, tax changes, regulatory actions, and cost pressures temper the near-term earnings outlook.
Philip Morris International Inc.
Philip Morris International delivered a strong Q2 2026 beat, with EPS of $2.20 exceeding consensus of $2.05 by 7.3% and revenue of $11.19B surpassing estimates of $10.60B by 5.6%. The smoke-free portfolio - IQOS, ZYN, and VEEV - remains the primary growth engine, delivering double-digit volume gains across many markets. Combustible sales also outperformed expectations, supported by strong pricing and emerging-market volume. Management maintained full-year guidance (5-7% revenue growth, 7-9% operating income growth, EPS $8.26-$8.41) despite accelerating U.S. investment in ZYN marketing and new product launches. The market responded positively, with shares rising 3.3% on the report and continuing to drift higher. The key question ahead is whether smoke-free momentum can offset rising regulatory and competitive headwinds in Japan and Europe.
Philip Morris International Inc.
PMI’s Q1 analysis supports a constructive but conditional view: smoke-free growth, pricing and mix remained strong, while reaffirmed guidance indicates management sees the trajectory as intact. The thesis depends on sustaining IQOS and ZYN momentum, managing inventory and navigating product approvals and tax risk.
Philip Morris International Inc.
The supplied analysis supports a constructive operating picture: smoke-free volume growth, pricing, geographic expansion, and productivity initiatives underpin management’s maintained 2026 outlook. The thesis is tempered by Japan tax changes, US regulatory uncertainty, and execution risk around new products.
Philip Morris International Inc.
The supplied analysis supports a constructive operating thesis: continued smoke-free adoption, pricing and capacity investment are supporting growth and margin expansion. The evidence is not one-sided, because regulatory changes, product-approval timing, ZYN normalization, currency and declining combustible volumes could limit the pace or durability of that growth.
Philip Morris International Inc.
The supplied analysis supports a constructive but conditional view: smoke-free adoption, pricing, scale, and product launches are supporting growth and margins, while ZYN supply constraints, regulation, mix, and macro uncertainty remain key tests.
Philip Morris International Inc.
The supplied analysis supports the view that resilient demand and earnings growth can underpin Philip Morris's outlook: smoke-free products drove Q3 growth, pricing and productivity supported margins, and management raised full-year guidance. The counterpoints are supply constraints, regulation, currency and litigation risks.
Philip Morris International Inc.
PM's raised outlook and strong IQOS and ZYN momentum support the case for continued earnings growth, but the thesis depends on converting smoke-free demand into capacity-supported volume while pricing and productivity offset regulatory and currency headwinds.
Get the PM recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.